Influence of comorbidities on transplant outcomes in patients aged 50 years or more after myeloablative conditioning incorporating fludarabine, BU and ATG. - El Kourashy, S.; Williamson, T.; Chaudhry, M. A.; Savoie, M. L.; Turner, A. R.; Larratt, L.; Storek, J.; Bahlis, N. J.; Brown, C. B.; Yang, M.; Quinlan, D.; Geddes, M.; et al. (Bone Marrow Transplantation, 2011)